McIlrath & Eck’s Humana HUM Stock Holding History

McIlrath & Eck’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38	Closed	-$17.4K	–	949
2023 Q4	$17.4K	Buy	38 +7	+23%	+$3.45K	﹤0.01%	441
2023 Q3	$15.1K	Sell	31 -8	-21%	-$3.76K	﹤0.01%	451
2023 Q2	$17.4K	Sell	39 -10	-20%	-$5.03K	﹤0.01%	445
2023 Q1	$23.8K	Buy	49 +2	+4%	+$989	0.01%	381
2022 Q4	$24.1K	Hold	47	–	–	0.01%	380
2022 Q3	$23K	Hold	47	–	–	0.01%	379
2022 Q2	$22K	Buy	47 +23	+96%	+$10.2K	0.01%	373
2022 Q1	$10K	Buy	+24	New	+$10K	﹤0.01%	525

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

McIlrath & Eck's HUM Position: Q1 2024 in Review

McIlrath & Eck sold out of Humana (HUM) in Q1 2024, closing a stake of 38 shares — an estimated $17.4K sold.

McIlrath & Eck first reported a position in HUM in Q1 2022 and held it in 8 quarters. The position peaked at $24.1K in Q4 2022. 1,030 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

McIlrath & Eck reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
McIlrath & Eck sold 38 Humana shares in Q1 2024, an estimated $17.4K.
McIlrath & Eck first reported a position in Humana in Q1 2022 and held it in 8 quarters.
McIlrath & Eck's Humana position peaked at $24.1K in Q4 2022.
1,030 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on McIlrath & Eck's 13F filing for Q1 2024, filed 10 May 2024.